Enzon Pharmaceuticals, Inc. (ENZN) Narrows Q2 Loss to 2c/Share
Tweet Send to a FriendGet Alerts ENZN Hot Sheet
Trade ENZN Now!
Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) reported Q2 EPS of ($0.02), versus ($0.13) reported last year. Revenue for the quarter came in at $9.8 million, versus $9.2 million reported last year.
For earnings history and earnings-related data on Enzon Pharmaceuticals, Inc. (ENZN) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Enzon Pharmaceuticals, Inc. (ENZN) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- salesforce.com, Inc. (CRM) Reports In-Line Q1 EPS; Issues In-Line Q2, FY14 Outlook
- Marvell Technology Group (MRVL) Tops Q1 EPS by 5c; Issues Solid Outlook
- Toro Co. (TTC) Tops Q2 EPS by 13c; Maintains Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
